Yang Liu, Zhang Shuguang, Guo Kai, Huang Hu, Qi Shuai, Yao Jie, Zhang Zhihong
Department of Cancer Biotherapy Center, Hubei Cancer Hospital, Wuhan, Hubei 430079, China.
Department of Clinical Laboratory, Liaocheng People's Hospital, Liaocheng, Shandong 252000, China.
Onco Targets Ther. 2018 Dec 24;12:205-215. doi: 10.2147/OTT.S168454. eCollection 2019.
Recently, many microRNAs have been found to be involved in the cancer progression including miR-125a. However, the underlying mechanisms of miR-125a in gastric cancer (GC) remain to be completely elucidated.
The study was to investigate the functional role of miR-125a and the expression relevance of signal transducer and activator of transcription 3 (STAT3) and hyaluronan synthase 1 (HAS1).
CCK-8 assay, scratch wound healing and transwell assay were conducted to identify the functional role of miR-125a in GC. In addition, using bioinformatics analysis, the target regulation relationship was found in STAT3 and miR-125a. To confirm the relationship, luciferase reporter assay was performed. More importantly, quantitative polymerase chain reaction and western blot assay were carried out to determine the association among miR-125a, STAT3 and HAS1 in GC cells.
Overexpressed miR-125a inhibited the migration and invasion of GC cells through scratch wound healing and transwell assay, and its knockdown displayed adverse effects, but the viability of GC cells did not show significant difference using CCK-8 assay. In addition, we identified that the knockdown of STAT3 or HAS1 remarkably suppressed the migration and invasion abilities of GC cells. Using bioinformatics analysis, miRTar, in particular, indicated that the 3'-untranslated region of STAT3 binds to miR-125a with a high score. Subsequently, we also verified that STAT3 was a target of miR-125a via luciferase reporter assay. Furthermore, we found that upregulated miR-125a expression could conspicuously constrain STAT3 expression at both protein and mRNA levels in MKN45 and NCI-N87 cells using quantitative polymerase chain reaction and Western blot assay, but no significant difference had been found in SGC 7901 cells. To further identify the regulatory relationship between miR-125a and STAT3, downregulation of miR-125a in MKN45 and NCI-N87 cells was carried out, which showed that the protein and mRNA expression levels of STAT3 were declined in two cell lines. Finally, we observed that upregulated miR-125a could lead to the decrease of HAS1 at protein and mRNA levels, whereas its knockdown revealed opposite effects. Meanwhile, we noticed that overexpression of STAT3 could induce the escalation of HAS1 at protein and mRNA expression levels and its knockdown exhibited the adverse outcomes.
These findings indicated that miR-125a may control the HAS1 expression in GC progression by targeting STAT3, which is likely to facilitate a better understanding of the regulation mechanisms of miR-125a in GC.
最近,人们发现许多微小RNA参与癌症进展,包括miR-125a。然而,miR-125a在胃癌(GC)中的潜在机制仍有待完全阐明。
本研究旨在探讨miR-125a的功能作用以及信号转导和转录激活因子3(STAT3)与透明质酸合酶1(HAS1)的表达相关性。
采用CCK-8法、划痕伤口愈合实验和Transwell实验来确定miR-125a在GC中的功能作用。此外,通过生物信息学分析,发现了STAT3与miR-125a之间的靶向调控关系。为了证实这种关系,进行了荧光素酶报告基因实验。更重要的是,采用定量聚合酶链反应和蛋白质印迹实验来确定GC细胞中miR-125a、STAT3和HAS1之间的关联。
通过划痕伤口愈合实验和Transwell实验,过表达的miR-125a抑制了GC细胞的迁移和侵袭,其敲低则产生相反作用,但使用CCK-8法检测GC细胞的活力未显示出显著差异。此外,我们发现敲低STAT3或HAS1可显著抑制GC细胞的迁移和侵袭能力。通过生物信息学分析,特别是miRTar表明,STAT3的3'-非翻译区与miR-125a具有高得分的结合。随后,我们还通过荧光素酶报告基因实验验证了STAT3是miR-125a的靶标。此外,我们发现使用定量聚合酶链反应和蛋白质印迹实验,上调miR-125a的表达可显著抑制MKN45和NCI-N87细胞中STAT3在蛋白质和mRNA水平的表达,但在SGC 7901细胞中未发现显著差异。为了进一步确定miR-125a与STAT3之间的调控关系,在MKN45和NCI-N87细胞中下调miR-125a,结果显示这两种细胞系中STAT3的蛋白质和mRNA表达水平均下降。最后,我们观察到上调miR-125a可导致HAS1在蛋白质和mRNA水平的降低,而其敲低则显示出相反的效果。同时,我们注意到过表达STAT3可诱导HAS1在蛋白质和mRNA表达水平的升高,其敲低则产生相反的结果。
这些发现表明,miR-125a可能通过靶向STAT3来控制GC进展中的HAS1表达,这可能有助于更好地理解miR-125a在GC中的调控机制。